Affiliation |
Graduate School of Medicine Doctorial Course in Medicine Bioregulatory Medicine Department of Medical Biology |
Date of Birth |
1972 |
Laboratory Address |
1-1-1 Hondo, Akita 010-8543, Japan |
Laboratory Phone number |
+81-18-884-6080 |
Mail Address |
|
EBIHARA Takashi
|
|
Research Interests 【 display / non-display 】
-
Chronic inflammation
-
Allergy
-
Infectious diseases
-
Immunity
-
Transcriptional regulation
Graduating School 【 display / non-display 】
-
-1998.03
Hokkaido University Faculty of Medicine Graduated
-
1992.04-1998.03
Hokkaido University Faculty of Medicine Graduated
Campus Career 【 display / non-display 】
-
2019.04-Now
Akita University Graduate School of Medicine Doctorial Course in Medicine Bioregulatory Medicine Professor
Academic Society Affiliations 【 display / non-display 】
-
2013.09-Now
Japan
Japanese Society for Immunology
Research Areas 【 display / non-display 】
-
Life Science / Experimental pathology
-
Life Science / Immunology / 自然リンパ球、NK細胞
-
Life Science / Experimental pathology / アレルギー、ウイルス感染、細菌感染
Research Career 【 display / non-display 】
-
Pediatric diseases caused by new emergent viruses including human metapneumovirus
Grant-in-Aid for Scientific Research
Periods of research:
2002.04-2005.03Classification of research form:Individual
Research Achievements 【 display / non-display 】
-
TIGIT mediates activation-induced cell death of ILC2s during chronic airway allergy.
Toshiki Yamada, Megumi Tatematsu, Shunsuke Takasuga, Akane Fuchimukai, Kenki Yamagata, Shinsuke Seki, Keiji Kuba, Hideyuki Yoshida, Ichiro Taniuchi, Günter Bernhardt, Kazuko Shibuya, Akira Shibuya, Takechiyo Yamada, Takashi Ebihara
The Journal of experimental medicine ( The Journal of experimental medicine ) 220 ( 7 ) 2023.07 [Refereed]
Research paper (journal) International Co-author
While group-2 innate lymphoid cells (ILC2s) are highly proliferative in allergic inflammation, the removal of overactivated ILC2s in allergic diseases has not been investigated. We previously showed that chronic airway allergy induces "exhausted-like" dysfunctional ILC2s expressing T cell immunoreceptor with Ig and ITIM domains (TIGIT). However, the physiological relevance of these cells in chronic allergy remains elusive. To precisely identify and monitor TIGIT+ ILC2s, we generated TIGIT lineage tracer mice. Chronic allergy stably induced TIGIT+ ILC2s, which were highly activated, apoptotic, and were quickly removed from sites of chronic allergy. Transcripts from coding genes were globally suppressed in the cells, possibly due to reduced chromatin accessibility. Cell death in TIGIT+ ILC2s was enhanced by interactions with CD155 expressed on macrophages, whereas genetic ablation of Tigit or blockade by anti-TIGIT antagonistic antibodies promoted ILC2 survival, thereby deteriorating chronic allergic inflammation. Our work demonstrates that TIGIT shifts the fate of ILC2s toward activation-induced cell death, which could present a new therapeutic target for chronic allergies.
-
Yui Miyabe, Hiroki Tomizawa, Hidekazu Saito, Toshiki Yamada, Kazuhiro Shiina, Koh Koizumi, Yohei Kawasaki, Shinsuke Suzuki, Mineyo Fukuchi, Shigeharu Ueki, Takashi Ebihara, Takechiyo Yamada
Allergy ( Wiley ) 77 ( 10 ) 3154 - 3156 2022.10 [Refereed]
Research paper (journal)
-
An J.
Oncogene ( Oncogene ) 2022 [Refereed]
Research paper (journal)
-
Trained innate lymphoid cells in allergic diseases
Ebihara Takashi, Tatematsu Megumi, Fuchimukai Akane, Yamada Toshiki, Yamagata Kenki, Takasuga Shunsuke, Yamada Takechiyo
Allergology International ( 一般社団法人日本アレルギー学会 ) 70 ( 2 ) 174 - 180 2021 [Refereed] [Invited]
Research paper (journal)
<p>Group 2 innate lymphoid cells (ILC2s) reside in peripheral tissues such as the lungs, skin, nasal cavity, and gut and provoke innate type 2 immunity against allergen exposure, parasitic worm infection, and respiratory virus infection by producing T<sub>H</sub>2 cytokines. Recent advances in understanding ILC2 biology revealed that ILC2s can be trained by IL-33 or allergic inflammation, are long-lived, and mount memory-like type 2 immune responses to any other allergens afterwards. In contrast, IL-33, together with retinoic acid, induces IL-10-producing immunosuppressive ILC2s. In this review, we discuss how the allergic cytokine milieu and other immune cells direct the generation of trained ILC2s with immunostimulatory or immunosuppressive recall capability in allergic diseases and infections associated with type 2 immunity. The molecular mechanisms of trained immunity by ILCs and the physiological relevance of trained ILC2s are also discussed.</p>
-
Exhausted-like Group 2 Innate Lymphoid Cells in Chronic Allergic Inflammation
Ebihara T, Taniuchi I
Trends in Immunology ( Trends in Immunology ) 40 ( 12 ) 1095 - 1104 2019.12 [Refereed] [Invited]
Research paper (journal) Domestic Co-author
-
Trained immunity and innate lymphoid cell memory
80 ( 1 ) 22 - 28 2023.07
Introduction and explanation (scientific journal)
-
Ccr4-NOT脱アデニル化酵素複合体は抗腫瘍性NK細胞活性を制御する(The Ccr4-Not deadenylase complex controls antitumor NK cell activity)
Tatematsu Megumi, Sawa Shinichiro, Ikuta Koichi, Ebihara Takashi
日本免疫学会総会・学術集会記録 ( (NPO)日本免疫学会 ) 50 ( Proceedings ) 3 - P 2021.11
Summary of the papers read (national conference and other science council)
-
ILC2の活性化により生じる細胞死は慢性アレルギー性炎症に対し保護的に働く(Activation-induced cell death of ILC2s confersprotection against chronic allergic inflammation)
Yamada Toshiki, Tatematsu Megumi, Ebihara Takashi
日本免疫学会総会・学術集会記録 ( (NPO)日本免疫学会 ) 50 ( Proceedings ) 3 - P 2021.11
Summary of the papers read (national conference and other science council)
-
肝特異的ホスファチジルグリセロールリン酸ホスファターゼ遺伝子欠損によるラロン型低身長症様疾患モデルマウス
高須賀 俊輔, 海老原 敬, 佐々木 雄彦
日本生化学会大会プログラム・講演要旨集 ( (公社)日本生化学会 ) 94回 [P - 991] 2021.11
Summary of the papers read (national conference and other science council)
-
T細胞(1) T細胞発生とレパートリー選択 免疫系の発達におけるC末端アミノ酸配列によるRunx3活性の制御(T cell: T cell development and repertoire selection Regulation of Runx3 activity in immune system development by the C-terminal end amino acid sequence)
Kojo Satoshi, Ebihara Takashi, Ohno-Oishi Michiko, Muroi Sawako, Taniuchi Ichiro
日本免疫学会総会・学術集会記録 ( (NPO)日本免疫学会 ) 46 ( Proceedings ) 2 - O/P 2017.12
Summary of the papers read (national conference and other science council)
-
免疫システム開発 免疫細胞発生におけるRunx転写因子の役割(Immunosystem development Roles of Runx Transcription Factors In Immune Cell Development)
Taniuchi Ichiro, Kojo Satoshi, Ebihara Takashi, Seo Wooseok, Tenno Mari
日本免疫学会総会・学術集会記録 ( (NPO)日本免疫学会 ) 46 ( Proceedings ) S8 - 5 2017.12
Summary of the papers read (national conference and other science council)
◆Original paper【 display / non-display 】
◆Introduction and explanation【 display / non-display 】
◆Other【 display / non-display 】
Books 【 display / non-display 】
-
RUNX Proteins in Development and Cancer
Takashi Ebihara, Wooseok Seo, Ichiro Taniuchi
Springer Link 2017.03 ISBN: 978-981-10-3233-2
Grant-in-Aid for Scientific Research 【 display / non-display 】
-
Grant-in-Aid for Scientific Research(C)
Project Year: 2022.04 - 2025.03
-
Grant-in-Aid for Scientific Research(C)
Project Year: 2022.04 - 2025.03
-
Grant-in-Aid for Challenging Research (Pioneering)/(Exploratory)
Project Year: 2021.04 - 2024.03
-
Grant-in-Aid for Scientific Research(B)
Project Year: 2021.04 - 2024.03
-
Grant-in-Aid for Scientific Research(C)
Project Year: 2021.04 - 2024.03
Presentations 【 display / non-display 】
-
Cnot3 differentially regulates development and function of innate lymphoid cells
Megumi Tatematsu, Akane Fuchimukai, Shunsuke Takasuga, Toshiki Yamada, Kenji Ishiwata, Ichiro Taniuchi, Shinichiro Sawa, Keiji Kuba, Takashi Ebihara
The 52nd Annual Meeting of the Japanese Society for Immunology 2024.01 - 2024.01
-
Exhaustion and Activation-Induced Cell Death of ILC2s in chronic allergy
Takashi Ebihara [Invited]
The 52nd Annual Meeting of the Japanese Society for Immunology 2024.01 - 2024.01
-
ACTIVATION-INDUCED CELL DEATH OF ILC2 REGULATES CHRONIC ALLERGIC INFLAMMATION
Yamada T, Tatematsu M, Takasuga S, Yamagata K, Shibuya K, Shibuya A, Yamada T, Ebihara T
4th International Conference on Innate Lymphoid Cells 2022.09 - 2022.09
Academic Activity 【 display / non-display 】
-
2019.09-Now
-
2019.09-Now
-
2019.04-Now